FDA Clearance Tracker · K234046
WallFlex Colonic Stent System with Anchor Lock Delivery System; WallFlex Duodenal Stent System with Anchor Lock Delivery System; WallFlex Colonic Soft Stent System with Anchor Lock Delivery System; WallFlex Duodenal Soft Stent System with Anchor Lock Delivery System
Last checked: Nov 20, 2026Latest source record: Mar 8, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Mar 8, 2024
Substantially Equivalent
Time to decision
78 days
Received Dec 21, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K234046
- Device name
- WallFlex Colonic Stent System with Anchor Lock Delivery System; WallFlex Duodenal Stent System with Anchor Lock Delivery System; WallFlex Colonic Soft Stent System with Anchor Lock Delivery System; WallFlex Duodenal Soft Stent System with Anchor Lock Delivery System
- Applicant
- Boston Scientific Corporation
- Applicant location
- Marborough, MA
- Received
- Dec 21, 2023
- Decided
- Mar 8, 2024
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Stent, Colonic, Metallic, Expandable (MQR)
- Device class
- Class II
- Regulation
- 21 CFR 878.3610
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MQR. The earliest in FDA's data is K954290, decided Jul 10, 1996.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K234046
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Boston Scientific Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SpaceOAR Flex System510(k)
K262151 · Decided Sep 11, 2026 · 78 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.